Ramat Hasharon, Israel

Tami Rashal

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Karyopharm Therapeutics Inc.. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tami Rashal. Retrieved from https://idiyas.com/inventor/tami-rashal

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Tami Rashal: Innovator in Wound Healing Technologies

Introduction

Tami Rashal is a notable inventor based in Ramat Hasharon, Israel. She has made significant contributions to the field of wound healing through her innovative research and development. Her work focuses on utilizing nuclear transport modulators to enhance the healing process.

Latest Patents

Tami Rashal holds a patent for "Methods of promoting wound healing using CRM1 inhibitors." This invention relates to the use of CRM1 inhibitors, which are compounds that facilitate nuclear transport. The patent outlines a method for promoting wound healing in subjects, showcasing the potential of these compounds in medical applications.

Career Highlights

Throughout her career, Tami has been associated with Karyopharm Therapeutics Inc., where she has contributed to groundbreaking research. Her expertise in the field has positioned her as a key player in the development of novel therapeutic strategies.

Collaborations

Tami has collaborated with esteemed colleagues, including Dilara McCauley and Sharon Shacham. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Tami Rashal's work in the field of wound healing exemplifies the impact of innovative research on medical science. Her contributions continue to pave the way for advancements in therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…